Latest International Operations News

BWP Trust proposes to internalise its management by acquiring BWP Management Limited from Wesfarmers for $142.6 million, restructure 62 Bunnings leases to extend lease terms and options, and commit $86 million to capital expenditure at key Bunnings sites. The transaction aims to enhance income certainty, reduce costs, and increase distributions for investors.

Bioxyne Limited's subsidiary Breathe Life Sciences has achieved key GMP certifications across multiple international markets, paving the way for expanded operations in Europe, the UK, Canada, and Singapore. The company signals strong growth prospects for FY2026, with formal guidance expected in August.

Cettire Limited reports a slight 1.7% increase in sales revenue for the year-to-date FY25 amid ongoing global luxury market challenges, including US tariff impacts and volatile demand. The company focuses on emerging markets expansion and improving profitability despite margin pressures.

AFT Pharmaceuticals has reported record revenue of NZD 208 million for FY25, driven by strong Australasian sales and a recovery in Asia and international markets. The company is targeting NZD 300 million in revenue by FY27, supported by an expanded R&D pipeline and ongoing geographic diversification.

GrainCorp reported a robust first half of FY25 with improved earnings and upgraded guidance, underpinned by strong East Coast grain volumes and operational resilience.

IDP Education Limited announces the appointment of Tracey Horton AO as Chair, succeeding Peter Polson after an 18-year tenure. This leadership change marks a key milestone in the company’s ongoing board renewal.

Zoom2u Technologies reports steady group revenue with Locate2u growing 10%, supported by AI initiatives that cut staff costs and a $0.5 million capital raise.

Ansell Limited has updated its FY25 interim dividend details, confirming a payment of USD 0.222 per share with an AUD equivalent of 0.3486, payable on March 6, 2025.

Reliance Worldwide Corporation Limited has announced an ordinary dividend of USD 0.025 per share for the six months ending December 31, 2024, payable in April 2025. The dividend is unfranked and will be paid in Australian dollars based on a recent exchange rate.

Lendlease Group has reported a robust turnaround in its half-year results, posting an operating profit after tax of $122 million and advancing its strategic capital recycling initiatives. The company is on track to reduce gearing and enhance operational efficiency amid ongoing market challenges.

Cochlear Limited has announced a fully franked dividend of AUD 2.15 per share for the six months ending December 2024, payable in multiple currencies on April 14, 2025.

Telix Pharmaceuticals has gained UK MHRA approval for Illuccix, its advanced prostate cancer PET imaging agent, promising to alleviate supply shortages and improve diagnostic accuracy across the UK.